StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 7/26/2014, (NASDAQ:MRK), $58.15 -0.06, -0.10%, "BUY" Merck & Compan Stock
 




  
  

MRK rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   7/26/2014   StockRing.com recommends to   "BUY"   MRK   stock at current price of   $58.15.
Today MRK stock opened at $58.13 and was trading in the daily range of $ 01809 per share.
Merck & Compan (NASDAQ:MRK) Market capitalization is $169.9B. MRK average daily volume is N/A.
On last trading session MRK stock traded 5,533,511 shares. Also the Short Ratio for (NASDAQ:MRK) stock is 43.626B.
Last year Merck & Compan(NASDAQ:MRK) before taxes (EBITDA) (ttm) earned $58.78 on revenue of $3.41.
MRK 50-Day Moving Average is $15.907B vs. $58.15 now and 200-Day Moving Average is $58.31 vs. $58.15.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "HOLD".  S&P 500 is "HOLD" on  5/16/2014
--------------------------------------------------------------------------------------------------------------------
MRK Earnings Per Share - EPS (ttm) is 1.52. MRK Stock Price Per Earnings ratio - P/E is 38.40.
Merck & Compan(NASDAQ:MRK) stock pays a dividend of $ " per share which is a yield of "NYSE"%.
On average analysts predict that One Year Target Estimated price for MRK stock is $56.21.
In the last 52 weeks MRK stock was trading in the range of $44.62 - 59.84.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

BUY  DOW 30+:    ENERGY: ADMA  RNG  CDW  CBA  BLUE     HEALTH: ACWX  EPHE  FM  DVYA  AOM 
      FINANCE: XLK  DWX  BWZ  GII  SCPB     SERVICES: UST  MLPX  BRAQ  YCL  EMFM     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: GGB     ENERGY: RMAX  SEAS  NBCB  PETX  VOYA     HEALTH: ITA  ICLN  EIRL  SCZ  PICK 
      FINANCE: XME  XSW  KBE  EWO  BAL     SERVICES: VIXM  EEV  UVXY  QID  AGQ     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



7/26/2014  Saturday, July 26, 2014 (Irvine, California) Today StockRing.com Recommendation is to "BUY"for Merck & Compan (NASDAQ:MRK) Stock. MRK stock opening price was $58.13 per share. Current price of NASDAQ:MRK Stock is $58.15 per share and it is $-0.06, (-0.10%) today and it was trading in the daily range of $01809 per share. Current Bid Price for (NASDAQ:MRK) stock is $3.01 and the Ask Price is $58.05. In the last 52 weeks MRK stock was trading in the range of $44.62 - 59.84. 50-Day Moving Average for (NASDAQ:MRK) stock is $15.907B and 200-Day Moving Average is $58.31. On average analysts predict that One Year Target Estimated price for (NASDAQ:MRK) stock is $56.21.

Merck & Compan (NASDAQ:MRK) is rated as a buy on 5/19/2014 11:03:20 PM.

Merck & Compan (NASDAQ:MRK) Market capitalization is $169.9B. (NASDAQ:MRK) stock average daily volume is N/A shares per day. However, on last trading session of Jul 25, 2012 MRK stock traded 5,533,511 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:MRK) stock is 43.626B. On previous trading session MRK Stock closed at $58.21 per share.

Last year Merck & Compan (NASDAQ:MRK) before taxes (EBITDA) (ttm) earned $58.78 on total revenue of $3.41. Earnings Per Share - EPS (ttm) for MRK stock is 1.52. Also, (NASDAQ:MRK) Stock Price Per Earnings ratio - P/E is 38.40. Thus, (NASDAQ:MRK) Stock Price/Sales (ttm) ratio is 60.94 and Price/Book (mrq) ratio is 3.90.

(NASDAQ:MRK) Stock pays a dividend of $ " per share which is a yield of "NYSE"%. So at this time (NASDAQ:MRK) Stock maintains Trailing Annual Dividend Rate at 3.00.


StockRing Recommendations for Merck & Compan (NASDAQ:MRK) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=MRK

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:MRK Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

MRK rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

7/26/2014 1 Year Stock market price chart for Merck & Compan (NASDAQ:MRK) Stock on Saturday, July 26, 2014
  
1 Year MRK 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
7/26/2014 5 days Stock market price chart for Merck & Compan (NASDAQ:MRK) Stock on Saturday, July 26, 2014
  
5 Days MRK 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:MRK Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

MRK rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

7/26/2014 Stock market price quote data for Merck & Compan (NASDAQ:MRK) Stock on Saturday, July 26, 2014

Last Trade: 58.15
Trade Time: Jul 25
Change: -0.06, (-0.10%)
Prev Close: 58.21
Open: 58.13
Bid: 3.01
Ask: 1.75
1y Target Est: $56.21
50-Day Moving Average: 15.907B
200-Day Moving Average:
58.31
Short Ratio: 43.626B
Trailing Annual Dividend Rate: 3.00
Day's Range: 01809
52wk Range: 44.62 - 59.84
Volume: 5,533,511
Avg Vol: N/A
Market Cap: 169.9B
P/E (ttm): 38.40
EPS (ttm): 1.52
Div & Yield: " ("NYSE"%)
Revenue (ttm): 3.41
Earnings before Tax (EBITDA) (ttm): 58.78
Price/Sales (ttm): 60.94
Price/Book (mrq): 3.90
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

MRK rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

MERCK CO INC(NYSE: MRK) Company Information

Merck & Co. Inc.
PO Box 100
One Merck Drive
Whitehouse Station, NJ 08889-0100
United States - Map
Phone: 908-423-1000
Fax: 908-735-1253
Web Site: http://www.merck.com

MERCK CO INC(NYSE: MRK) DETAILS

MERCK CO INC(NYSE: MRK) Index Membership: Dow Jones Composite Dow Industrials S&P 100 S&P 500 S&P 1500 Super Comp
MERCK CO INC(NYSE: MRK) Sector: Healthcare
MERCK CO INC(NYSE: MRK) Industry: Drug Manufacturers - Major
MERCK CO INC(NYSE: MRK) Full Time Employees: 52,700

MERCK CO INC(NYSE: MRK) BUSINESS SUMMARY

Merck & Co., Inc. provides products for human and animal health in the United States and internationally. The company?s Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents. Its products comprise Singulair, a leukotriene receptor antagonist for the treatment of asthma and allergic rhinitis; Cozaar, Hyzaar, Vasotec, and Vaseretic, the hypertension and/or heart failure products; Fosamax and Fosamax Plus D for treating osteoporosis; Januvia and Janumet for type 2 diabetes; Cosopt and Trusopt, the ophthalmological products; Zocor, an atherosclerosis product; Maxalt for acute migraine; Propecia to treat male pattern hair loss; Arcoxia to treat arthritis and pain; Proscar to treat symptomatic benign prostate enlargement; and Emend for the prevention of chemotherapy-induced and post-operative nausea and vomiting. Merck & Co.?s Vaccines segment comprises human health vaccines, such as preventative pediatric, adolescent, and adult vaccines. Its products include Gardasil to prevent cervical cancer, pre-cancerous and low-grade lesions, vulvar and vaginal pre-cancers, and genital warts; Varivax to prevent chickenpox; ProQuad, a pediatric combination vaccine against measles, mumps, rubella, and varicella; M-M-R II, a vaccine against measles, mumps, and rubella; RotaTeq to protect against rotavirus gastroenteritis in children; Zostavax for preventing shingles; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Isentress, Crixivan, and Stocrin, antiretroviral therapies for the treatment of HIV infection; and Invanz for the treatment of infection. Merck & Co. has research, collaboration, or licensing agreements with Neuromed Pharmaceuticals, Ltd.; ARIAD Pharmaceuticals, Inc.; GTX, Inc.; Idera Pharmaceuticals; Japan Tobacco Inc.; Galapagos NV; AstraZeneca plc; Metabasis Therapeutics Inc.; and Addex Pharmaceuticals Ltd. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

MERCK CO INC(NYSE: MRK) KEY EXECUTIVES

Mr. Richard T. Clark , 63 Exec. Chairman, Chief Exec. Officer and Pres $ 4.03M $ 0

Mr. Peter N. Kellogg , 52 Chief Financial Officer and Exec. VP $ 1.60M $ 0

Mr. Kenneth C. Frazier , 54 Exec. VP and Pres of Global Human Health $ 2.00M $ 0

Dr. Peter Kim Ph.D., 50 Exec. VP and Pres of Merck Research Laboratories $ 1.91M $ 0

Mr. Bruce N. Kuhlik , 52 Exec. Vice president and Gen. Counsel $ 1.25M $ 0



7/26/2014 Latest stock market news data for Merck & Compan (NASDAQ:MRK) Stock on Saturday, July 26, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

MRK rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

Merck lays off 600 more employees at North Wales, Lansdale offices
The Times Herald - 18 hours ago
The Philadelphia Business Journal says the information comes from a Worker Adjustment and Retraining Notification (WARN) notice the pharmaceutical company filed with the Pennsylvania Department of Labor and Industry. Merck officials were not ...
Merck & Co. Inc.: I'm Long, But It Screams Overvalued Today (MRK)
Seeking Alpha - Jul 24, 2014
... I wrote that article at the beginning of 2014 I felt KO was undervalued, purchased it and am now sitting on a nice 8.2% return, excluding dividends, in just over half a year.
Merck & Co., Inc. (MRK) Declares Quarterly Dividend of $0.44 - WKRB News
Merck Announces Fourth-Quarter 2014 Dividend - The Wall Street Transcript
Merck Looks Overpriced Compared To This Sector Peer
Seeking Alpha (registration) - Jul 24, 2014
Merck (NYSE:MRK) provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
Company Update: Merck & Co Inc (NYSE:MRK) – Merck Initiates Phase 3 Study ...
Jutia Group - Jul 24, 2014
Merck & Co Inc (NYSE:MRK) [Business Wire] - Merck , known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir , an investigational antiviral agent.
Interesting August Stock Options for Merck
Forbes - Jul 14, 2014
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co Merck & Co., Inc (NYSE: MRK). So this week we highlight one interesting put contract, and one interesting call contract ...
Investors Watch List – Pfizer Inc. (NYSE:PFE), Merck & Co. Inc. (NYSE:MRK ...
Crazy Joys - Jul 24, 2014
Shares of Pfizer Inc. (NYSE:PFE) have received a consensus rating of “Buy” from the seventeen ratings firms that are covering the company, Stock Ratings Network reports. Six analysts have rated the stock with a hold recommendation and nine have ...
Should Dividend Investors Eject Merck & Co., Inc?
Motley Fool - Jun 27, 2014
Merck (NYSE: MRK ) has one of the largest dividends in health care, but does that make it one of the sector's top dividend stocks?
Drug Maker Overtraded List- AbbVie Inc (NYSE:ABBV), Merck & Co., Inc. (NYSE ...
eMarketsDaily - Jul 23, 2014
AbbVie Inc. (ABBC) could realize around $8B in tax breaks over the next 15 years as a result of its merger by means of Shire PLC, as well as it may need that savings if sales of its primary revenue source, the arthritis drug Humira, persist to dip as ...
Merck: Buy The Dip... But Not Yet (MRK)
Seeking Alpha - Jul 2, 2014
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
Insider Selling: Merck & Co. Insider Sells 72290 Shares of Stock (MRK) - Ticker Report
Merck & Co. Given New $61.00 Price Target at Barclays (MRK) - Watch List News (press release)
Investors Are Watching – Merck & Co (NYSE:MRK), The Walt Disney (NYSE:DIS ...
Crazy Joys - 23 hours ago
Merck & Co. Inc. (NYSE:MRK) known as MSD outside the United States and Canada, announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir (MK-8228), an investigational antiviral agent.

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

MRK rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


7/26/2014 News from StockRing Blog about Merck & Compan (NASDAQ:MRK) Stock on Saturday, July 26, 2014



Copyright © 2014 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds   Form

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.